2014
DOI: 10.1097/prs.0000000000000433
|View full text |Cite
|
Sign up to set email alerts
|

Collagenase Clostridium histolyticum Injection for Plantar Fibromatosis (Ledderhose Disease)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(10 citation statements)
references
References 4 publications
0
10
0
Order By: Relevance
“…Nonsurgical treatment options include intralesional cortisone or collagenase injections [10], stretching, orthotics, anti-inflammatory drugs, physical therapy, shockwave therapy [11], and radiotherapy [12]. …”
Section: Discussionmentioning
confidence: 99%
“…Nonsurgical treatment options include intralesional cortisone or collagenase injections [10], stretching, orthotics, anti-inflammatory drugs, physical therapy, shockwave therapy [11], and radiotherapy [12]. …”
Section: Discussionmentioning
confidence: 99%
“…A case study examining CCH for plantar fibromas (injected with 0.58 mg in 0.25 mL for a period of 3 injections with 1-month intervals) failed to show improvement in nodule size, softening or painful ambulation. 42 Side effects of CCH injections include erythema, ecchymosis, and pain at the injection site.…”
Section: Collagenasementioning
confidence: 99%
“…Collagenase is a matrix metalloprotease that breaks down peptide bonds in order to dissolve interstitial collagen. Collagenase Clostridium histolyticum (CCH) is a mixture of two collagenases (AUX-1 and AUX-2) that has been shown to decrease contractions in Peyronie’s and Dupuytren’s and is currently being studied as a treatment option for PF 9,36. A recent study tested the effectiveness of CCH by injecting it into a nodule once a month for 3 months; this failed to improve nodule size, softening, or pain with ambulation 36.…”
Section: Non-operative Managementmentioning
confidence: 99%
“…Collagenase Clostridium histolyticum (CCH) is a mixture of two collagenases (AUX-1 and AUX-2) that has been shown to decrease contractions in Peyronie’s and Dupuytren’s and is currently being studied as a treatment option for PF 9,36. A recent study tested the effectiveness of CCH by injecting it into a nodule once a month for 3 months; this failed to improve nodule size, softening, or pain with ambulation 36. It is likely that the anatomical nature of PF (nodules) compared with that of Peyronie’s and Dupuytren’s (plaques and cords) plays a role in the ineffectiveness of CCH for treatment of the former.…”
Section: Non-operative Managementmentioning
confidence: 99%